Cost analysis of narrowband UVB phototherapy in psoriasis - 24/08/11
Abstract |
Background |
There are few data available to health care providers regarding the costs of treating patients with psoriasis, and specifically the cost of phototherapy.
Objectives |
As narrowband UVB (TL-01) has now become an established therapy for patients with psoriasis requiring phototherapy, we determined the annual cost of delivering TL-01 treatment in a university hospital.
Methods |
The costing evaluation was from a hospital perspective and the strategy used was a microcosting detailed collection of resources used.
Results |
The annual cost of TL-01 treatment in our teaching hospital was 53,555.00 euros. Staffing accounted for 70% of the cost. The average individual costs were 325.00 euros (range: 57.20-972.40).
Conclusion |
These costs are significant but remain less expensive than inpatient treatment.
Le texte complet de cet article est disponible en PDF.Plan
 | Funding sources: None. Conflicts of interest: None identified. |
Vol 50 - N° 4
P. 623-626 - avril 2004 Retour au numéro
Article précédent
- Psoriasis
- John Koo, Ernest Lee, Chai Sue Lee, Mark Lebwohl
- A man with distinctive facial features and recurrent pyoderma, pneumonia, and skeletal fractures
- Christine L Tock, Steven M Holland, Jennifer M Puck, Maria L Turner
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?